Skip to main content

Nohla adds $11 million in funding and three new investors

Nohla has raised $111 million toward improving the use of umbilical cord blood instead of bone marrow in stem-cell transplants to treat cancer and other diseases.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.